Global Rosuvastatin Calcium Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Rosuvastatin Calcium Tablets Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Rosuvastatin Calcium Tablets report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2024. Global Rosuvastatin Calcium Tablets market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Rosuvastatin Calcium Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034.
Globally, Rosuvastatin Calcium Tablets key manufacturers include AstraZeneca, Shanghai Pharmaceuticals Holding Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Teva, Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Ningbo Krka Menovo Pharmaceutical Co., Ltd., Qingdao Huanghai Pharmaceutical Co.,Ltd., Chifeng Saliont Pharmaceutical Co., Ltd. and Yichang Hec Changjiang Pharmaceutical Co., Ltd., etc. AstraZeneca, Shanghai Pharmaceuticals Holding Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2024.
Rosuvastatin Calcium Tablets can be divided into 5mg, 10mg, 20mg and 40mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2024.
Rosuvastatin Calcium Tablets is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Rosuvastatin Calcium Tablets industry development. In 2024, global % sales of Rosuvastatin Calcium Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rosuvastatin Calcium Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca
Shanghai Pharmaceuticals Holding Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Teva
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Ningbo Krka Menovo Pharmaceutical Co., Ltd.
Qingdao Huanghai Pharmaceutical Co.,Ltd.
Chifeng Saliont Pharmaceutical Co., Ltd.
Yichang Hec Changjiang Pharmaceutical Co., Ltd.
Shanxi Lanhua Pharmaceutical Co., Ltd
Asterisk Laboratories
Biocon
Aurobindo Pharma
Citron Pharma
Sandoz
Segment by Type
5mg
10mg
20mg
40mg
Hospital
Clinic
Other
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rosuvastatin Calcium Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rosuvastatin Calcium Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rosuvastatin Calcium Tablets industry.
Chapter 3Historical (2018-2024) and forecast (2024-2034) volume and revenue analysis of Rosuvastatin Calcium Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rosuvastatin Calcium Tablets introduction, etc. Rosuvastatin Calcium Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rosuvastatin Calcium Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Rosuvastatin Calcium Tablets industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2034.
Globally, Rosuvastatin Calcium Tablets key manufacturers include AstraZeneca, Shanghai Pharmaceuticals Holding Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd., Teva, Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd., Ningbo Krka Menovo Pharmaceutical Co., Ltd., Qingdao Huanghai Pharmaceutical Co.,Ltd., Chifeng Saliont Pharmaceutical Co., Ltd. and Yichang Hec Changjiang Pharmaceutical Co., Ltd., etc. AstraZeneca, Shanghai Pharmaceuticals Holding Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd. are top 3 players and held % sales share in total in 2024.
Rosuvastatin Calcium Tablets can be divided into 5mg, 10mg, 20mg and 40mg, etc. 5mg is the mainstream product in the market, accounting for % sales share globally in 2024.
Rosuvastatin Calcium Tablets is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Rosuvastatin Calcium Tablets industry development. In 2024, global % sales of Rosuvastatin Calcium Tablets went into Hospital filed.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rosuvastatin Calcium Tablets market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Shanghai Pharmaceuticals Holding Co., Ltd.
Zhejiang Hisun Pharmaceutical Co., Ltd.
Teva
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Ningbo Krka Menovo Pharmaceutical Co., Ltd.
Qingdao Huanghai Pharmaceutical Co.,Ltd.
Chifeng Saliont Pharmaceutical Co., Ltd.
Yichang Hec Changjiang Pharmaceutical Co., Ltd.
Shanxi Lanhua Pharmaceutical Co., Ltd
Asterisk Laboratories
Biocon
Aurobindo Pharma
Citron Pharma
Sandoz
Segment by Type
5mg
10mg
20mg
40mg
Segment by Application
Hospital
Clinic
Other
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rosuvastatin Calcium Tablets market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rosuvastatin Calcium Tablets, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rosuvastatin Calcium Tablets industry.
Chapter 3Historical (2018-2024) and forecast (2024-2034) volume and revenue analysis of Rosuvastatin Calcium Tablets in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rosuvastatin Calcium Tablets introduction, etc. Rosuvastatin Calcium Tablets Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rosuvastatin Calcium Tablets market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.